Company Analysis

InMed Pharmaceuticals Inc. (INM)

Nasdaq: INM · Pharmaceutical Preparations · Vancouver, BC · filing with the SEC since 2018
Grade4.7
◀ Past 4.1● Present 3.2▶ Future 6.4
2 est.

Who owns InMed Pharmaceuticals Inc.

As filed with the SEC
Holders of 5% or more
5
Vivo Opportunity Fund Holdings, L.P. holds 21.7% of Common Shares, no par value, as its SCHEDULE 13D filed Jun 10, 2026 says.
Directors and officers
16
report now, of 26 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Vivo Opportunity Fund Holdings, L.P.
SCHEDULE 13D · filed Jun 10, 2026 · Common Shares, no par value
21.7%
ADAR1 Capital Management, LLC
SCHEDULE 13G/A · filed Oct 7, 2026 · Common Shares, no par value · 24.1% in Jun 5, 2026
17.2%
YA II PN, Ltd.
9.99%
Sabby Management, LLC
SCHEDULE 13G · filed Jan 20, 2026 · Common Stock · 4.9% in Jan 3, 2025
9.9%
Squadron Master Fund LP
SCHEDULE 13G · filed May 27, 2026 · Common Shares, no par value
9.8%
Ikarian Capital, LLC
SCHEDULE 13G · filed Aug 14, 2026 · Common Shares, no par value · reported falling below 5%
under 5%
AdvisorShares Trust
SCHEDULE 13G/A · filed Apr 2, 2025 · Common Shares, no par value · reported falling below 5%
under 5%
What INM reports owning in othersstakes of 5% or more, and other ties

4 subsidiaries in 1 country, from the list filed with the 10-K filed Sep 30, 2024.

Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
212224
2024 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 32 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Vivo Opportunity, LLC10% owner0$0024$400,000
Adar1 Capital Management, LLC10% owner0$0014$100,000
Schneeberger Daniel10% owner0$006$800,000
Vivo Opportunity Cayman Fund, L.P.10% owner0$006$0
SI Assistanton INM · research, not advice